HACKMAN JEFFREY 4
4 · NOVELION THERAPEUTICS INC. · Filed Nov 1, 2017
Insider Transaction Report
Form 4
HACKMAN JEFFREY
Exec. VP and COO
Transactions
- Award
Stock Option (Right to Buy)
2017-11-01+135,000→ 135,000 totalExercise: $4.71Exp: 2027-11-01→ Common Shares (135,000 underlying) - Award
Common Stock
2017-11-01+50,000→ 50,000 total - Award
Common Stock
2017-11-01+92,500→ 142,500 total
Footnotes (5)
- [F1]These shares are issuable pursuant to a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The restricted stock units vest in three equal annual installments beginning November 1, 2018.
- [F3]The restricted stock units vest in full on November 1, 2018.
- [F4]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F5]This stock option award will vest and become exercisable in three equal annual installments beginning November 1, 2018.